Lynne Chou O'Keefe is the Founder and Managing Partner of Define Ventures. She previously worked at Kleiner Perkins Caufield & Byers as a Partner. Before joining KPCB, Lynne has over twelve years of healthcare operating and investing experience. Most recently, Lynne worked for eight years at Abbott Vascular and Guidant in multiple roles and has worked on the launch of over ten interventional cardiology and cardiac surgery product families both in the US and internationally. Most recently, Lynne lead the global launch of Absorb, the world’s first bioresorbable vascular scaffold, recognized by Wall Street Journal as Medical Device Technology Innovation of the Year and Popular Mechanics.
Location
United States
Notable investments
No items found.
Check size range(s)
$500K - $1M
$1M - $3M
$3M - $10M
Rounds their fund invests in
Seed
Series A
Rounds their fund leads
No items found.
Sectors their fund invests in
Health
Geographies their fund invests in
USA
![](https://cdn.prod.website-files.com/62f3f3ccd0cfd515f3b095e4/6601d814595d501c6adfa00a_Harmonic%20AI.jpg)
Browse through a massive startup database
Browse Harmonic, our favorite resource for parsing through the world's startup data.
Partner
Learn more about Harmonic
No items found.
No colleagues here yet.
Funds they're a part of
Define Ventures
About the Fund
Focuses on investing in early-stage digital health companies that will redefine healthcare.
View Profile
Their Colleagues
No colleagues here yet.
Sheets Their fund(s) are in
Is this you? Have any edits?
Fill out our update request form and we'll update ASAP
Related Investors
Round-focused Sheets
Geography-focused Sheets
Sector-focused Sheets